Borna disease virus (BDV) transcribes and replicates its nonsegmented negative-strand (NNS) RNA genome in the nucleus of infected cells. This nuclear phase of the virus life cycle is unique among members of the NNS RNA animal viruses (3, 5) . Following translation in the cytoplasm, BDV proteins must travel through the nuclear membrane and into the nucleus in order to participate in virus transcription. Three mechanisms are described to account for cytoplasmic-nuclear trafficking: passive diffusion, active transport, and cotransport (16).
Borna disease virus (BDV) transcribes and replicates its nonsegmented negative-strand (NNS) RNA genome in the nucleus of infected cells. This nuclear phase of the virus life cycle is unique among members of the NNS RNA animal viruses (3, 5) . Following translation in the cytoplasm, BDV proteins must travel through the nuclear membrane and into the nucleus in order to participate in virus transcription. Three mechanisms are described to account for cytoplasmic-nuclear trafficking: passive diffusion, active transport, and cotransport (16) .
Active transport requires soluble cytoplasmic receptors called karyopherins (in yeast cells) or importins (in mammalian cells), energy in the form of GTP (in many but not all cases), and a specific nuclear localization signal(s) (NLS[s]) within the primary amino acid sequence of the karyophilic protein (6) . At least four active transport pathways have been described previously (1) . Each requires that importins recognize and interact directly with the NLS of the protein to be imported. The importin-NLS protein complex then docks at fibrils extending from the nuclear pore complex and is imported into the nucleus through a series of interactions that utilize energy in the form of GTP. Cotransport occurs when a protein that lacks an NLS and is too large for passive diffusion interacts with a protein that contains a functional NLS (1). The proteins are subsequently cotransported into the nucleus via active transport due to the presence of the NLS.
Functional NLSs have been mapped within the BDV nucleoprotein (N) (8, 10) , phosphoprotein (P) (12, 13) , and X protein (X) (17) . The N-NLS is similar in sequence and aminoterminal position to the NLSs of the VP1 proteins of simian virus 40 (SV40) and polyomavirus (10) . In contrast, P contains two NLSs (12, 13) . The first is located near the amino-terminal portion of P and is bipartite, similar to the nucleoplasmin NLS (12) . The second is located at the carboxyl-terminal portion of P (12, 13); both P-NLSs are unique in that proline residues play a central role in their activity (13) . X import is mediated by interaction of a nonconventional karyophilic signal at its amino terminus with importin-␣ (17) . We demonstrated previously (15) that BDV P and the RNA-dependent RNA polymerase (L) interact. This interaction alone could lead to nuclear localization of L due to the P-NLS; however, immunohistochemical studies with anti-L1 antisera and BSR-T7 cells (Huh-7 cells stably transfected to express T7 RNA polymerase) transiently transfected with an L-expression plasmid revealed the presence of L protein in the nucleus (15) . This finding suggested the presence of an NLS(s) in L. To characterize the putative L-NLS, immunofluorescence analyses of BSR-T7 cells transfected with wild-type or mutant forms of L fused to a flag epitope tag or ␤-galactosidase were performed. Analysis of amino-and carboxyl-truncation mutants fused to the flag epitope tag indicated that the central residues of L (amino acids 824 to 1062) were sufficient for nuclear localization. These results were confirmed and expanded by analysis of L-␤-galactosidase fusion constructs. A strong NLS at residues 844 to 852 was identified. Mutation of 844R (arginine) and 847K (lysine) to A (alanine) led to cytoplasmic accumulation of L, confirming that these residues within the sequence 844RVVKLRIAP852 are necessary and sufficient for nuclear localization of L. Subcellular distribution of L-flag epitope tag fusions. The subcellular distribution of L-flag epitope tag fusion proteins was determined immunohistochemically with anti-flag M2 murine antibody (Sigma) and goat anti-mouse immunoglobulin G (IgG) fluorescein isothiocyanate (Caltag) in BSR-T7 cells transiently transfected with expression plasmids encoding the flag epitope tag fused to amino-or carboxyl-deletion mutants of BDV L. Both full-length L fused to the flag epitope tag (pTM-TL) and the 394-amino-acid (aa) amino-terminal deletion mutant (pTM-T⌬N394) fused to the flag epitope tag localized to the nucleus of transfected BSR-T7 cells (Fig. 1A , B, and F). In contrast, the 953-aa carboxyl-terminal deletion mutant fused to the flag epitope tag (pTM-T⌬C759) ( Fig. 1A and C) and the 1,062-aa amino-terminal deletion mutant fused to the flag epitope tag (pTM-T⌬N1062) ( Fig. 1A and E) localized to the cytoplasm. Deletion of 1,532 aa from the carboxyl region of L (pTM-Z⌬C180) resulted in predominantly cytoplasmic fusion protein ( Fig. 1A and D) . No fluorescence was observed in cells transfected with vector (pTM1) alone (Fig. 1G) .
Subcellular localization of ␤-galactosidase-L fusion proteins. The subcellular distribution of ␤-galactosidase-L fusion proteins was assessed by indirect immunofluorescence, using murine anti-␤-galactosidase (primary antibody) (Sigma) and anti-mouse IgG fluorescein isothiocyanate (secondary antibody) (Caltag) after transient transfection of BSR-T7 cells with plasmids that encode ␤-galactosidase fused to amino-or carboxyl-deletion mutants of BDV L (Fig. 2A) . Whereas ␤-galactosidase alone was cytoplasmic (Fig. 2B, panel i) , ␤-galactosidase fused to wild-type L (pTM-ZL) (Fig. 2B, panel a) was nuclear. Deletion of 888 (pTM-Z⌬C824) (Fig. 2B, panel b) , 953 (pTM-Z⌬C759) (Fig. 2B, panel c) , or 1,532 (pTM-Z⌬C180) (Fig. 22B, panel d) aa from the carboxyl region of L led to cytoplasmic staining. In contrast, deletion of 561 (pTM-Z⌬N561) (Fig. 2B, panel h ) or 824 (pTM-Z⌬N824) (Fig. 2B,  panel g ) aa from the amino region of L retained the nuclear staining pattern. Further deletion from the amino region of L again led to cytoplasmic localization of the fusion proteins, as observed upon deletion of 1,062 (pTM-Z⌬N1062) (Fig. 2B , panel f) or 1,439 (pTM-Z⌬N1439) (Fig. 2B , panel e) amino residues. Fusion of L aa 824 to 1062 (pTM-Z⌬N824C1062) (Fig. 3C, panel a) , 824 to 941 (pTM-Z⌬N824C941) (Fig. 3C , panel e) or 824 to 853 (pTM-Z⌬N824C853) (Fig. 3C , panel f) led to nuclear localization of ␤-galactosidase. In contrast, all ␤-galactosidase-L fusions that contained L sequence carboxyl to aa 854 localized to the cytoplasm: aa 921 to 1062 (pTM-Z⌬N921C1062) (Fig. 3C, panel b) , 921 to 1015 (pTM-Z⌬N921C1015) (Fig. 3C, panel c) , or 854 to 1,015 (pTM-Z⌬N854C1015) (Fig. 3C, panel d) . No fluorescence was observed in cells transfected with empty vector (pTM1) (Fig.  2B, panel j and 3C, panel g ).
L-NLS mutant localizes to the cytoplasm. Analysis of L truncation mutants fused with the flag epitope tag and ␤-galactosidase suggested that an L-NLS was located between aa 824 to 853. To test this hypothesis, BSR-T7 cells were transfected with a plasmid encoding L-NLS mutants Arg844Ala and Lys847Ala (R844A/K847A). Subcellular distribution of the mutant protein within transfected cells was assessed by indirect immunofluorescence using murine anti-L1 primary antisera and anti-mouse IgG fluorescein isothiocyanate (secondary antibody) (Caltag). Whereas wild-type L localized to the nucleus (Fig. 4b) , the mutant protein localized to the cytoplasm ( (Fig. 4c) . Expression of L-fusion proteins and mutant proteins of the predicted size. The size of proteins expressed in BSR-T7 cells transfected with plasmids encoding ␤-galactosidase-L fusions, L-flag epitope tag fusions, or the L-NLS mutant was determined by Western immunoblotting using murine anti-flag M2 primary antibody (Sigma) (Fig. 5) , murine anti-␤-galactosidase primary antibody (Sigma) (Fig. 6) , or murine anti-L1 antisera (Fig. 7) , followed by goat anti-mouse IgG secondary antibody conjugated to horseradish peroxidase (Sigma). L-flag epitopetagged fusion proteins of the predicted sizes were detected as follows: pTM-T⌬C180, 20 kDa (Fig. 5A, lane 1) ; pTM-T⌬N1062, 85 kDa (Fig. 5B, lane 1) ; pTM-T⌬C759, 95 kDa (Fig. 5B, lane 2) ; pTM-T⌬N394, 150 kDa (Fig. 5B, lane 3) ;and pTM-TL, 190 kDa (Fig. 5C, lane 2) . Fusions of ␤-galactosidase-L expressed from plasmids were also consistent as far as their predicted sizes: pTM-ZL, 310 kDa (Fig. 6A, lane 2 pTM-Z⌬C824, 200 kDa (Fig. 6A, lane 3) ; pTM-Z⌬C759, 200 kDa (Fig. 6A, lane 4) ; pTM-T⌬C180, 140 kDa (Fig. 6A, lane  5) ; pTM-Z⌬N1439, 150 kDa (Fig. 6A, lane 6) ; pTM-Z⌬N1062, 190 kDa (Fig. 6A, lane 7) ; pTM-Z⌬N824, 220 kDa (Fig. 6A, lane  8) ; pTM-Z⌬N561, 240 kDa (Fig. 6A, lane 9) ; pTM-Z⌬ N824C1062, 146 kDa (Fig. 6B, lane 2) ; pTM-Z⌬N921C1062, 135 kDa (Fig. 6B, lane 3) ; pTM-Z⌬N921C1015, 130 kDa (Fig. 6B,  lane 4) ; pTM-Z⌬N854C1015, 140 kDa (Fig. 6B, lane 5) ; pTM-Z⌬N824C941, 133 kDa (Fig. 6B, lane 6) ; and pTM-Z⌬N824C853, 123 kDa (Fig. 6B, lane 7) . L-NLS mutant protein of the predicted size (190 kDa) was expressed from pTM-L-AVVA (Fig. 7, lane 2) . Proteins consistent with the size of those expressed from expression plasmids were not detected upon transfection with empty vector (pTM-1) (Fig. 5A, lane 2 BDV replicates in the nucleus of infected cells (3, 5) . Thus, the BDV polymerase must localize to the nucleus of infected cells (15) . Nuclear localization of BDV L could result from an NLS or from cotransport with other viral proteins (16) . BDV L interacts with BDV-P (15), which has a strong NLS (12, 13) ; thus, it is conceivable that BDV L is cotransported into the nucleus with BDV P. However, in the absence of P, recombinant L localizes to the nucleus of transfected BSR-T7 cells (15) , indicating the presence of an NLS, which we characterized.
To identify the NLS of BDV L, a flag epitope tag was fused with the wild type and with amino and carboxyl deletions of L (Fig. 1A) . Indirect immunofluorescence with murine anti-flag M2 antibody (Sigma) on BSR-T7 cells transfected with expression plasmids showed clear nuclear staining when residues 759 to 1062 were present (Fig. 1B to F) . Amino-and carboxyldeletion mutants of L fused to ␤-galactosidase confirmed the result observed with L-flag epitope tag fusions and were used to further narrow the sequence to residues 824 to 1062 (Fig.  2B, panels a to i) .
Fine mapping of the L-NLS was performed by fusion of L to ␤-galactosidase in order to ensure that fusion proteins were more than 60 kDa, the threshold for passive diffusion into the nucleus (14) . Ultimately, residues 824 to 853 were identified as sufficient to drive nuclear localization of the ␤-galactosidase fusion protein (Fig. 3C , panels a to f). Analysis of this sequence indicated a strong NLS at residues 844 to 854. The activity of the NLS was confirmed by mutating the sequence within L (R844A/K847A). This L-NLS mutant localized to the cytoplasm of BSR-T7 cells (Fig. 4a) . This region contained a stretch of basic residues similar to the SV40 class of NLSs (844RVVKLR849) (9) . It is likely that these residues represent the core L-NLS. Core NLSs are usually defined by a hexapeptide, with K and R residues and either V, P, or A residues interspersed (9). P, G, or acidic residues flank The results presented here with respect to L and elsewhere with respect to N, P, and X, confirm the intimate association between BDV and the host cell nucleus predicted by Sasaki and Ludwig (11) and Gosztonyi and Ludwig (7). 
